SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-053337
Filing Date
2020-04-29
Accepted
2020-04-29 16:01:46
Documents
7
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K/A tm2017850-1_10ka.htm 10-K/A 674777
2 EXHIBIT 31.1 tm2017850d1_ex31-1.htm EX-31.1 3686
3 EXHIBIT 31.2 tm2017850d1_ex31-2.htm EX-31.2 3750
4 EXHIBIT 32.1 tm2017850d1_ex32-1.htm EX-32.1 7579
5 GRAPHIC tm2017850-1_10kimg001.jpg GRAPHIC 2793
6 GRAPHIC tm2017850-1_10kimg002.jpg GRAPHIC 170985
7 GRAPHIC tm2017850-1_10kimg003.jpg GRAPHIC 18991
  Complete submission text file 0001104659-20-053337.txt   956875
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19756 | Film No.: 20830129
SIC: 2836 Biological Products, (No Diagnostic Substances)